Cover Image

Use of Methotrexate in the Treatment of Moderate to Severe Plaque Psoriasis in France: A Practice Survey

Anne-Claire Fougerousse,1 Laure Mery-Bossard,2 Josiane Parier,3 Charles Taieb,4 Antoine Bertolotti,5,6 Francois Maccari3 On behalf of GEM ResoPso1Dermatology Department, Hôpital d’Instruction des Armées Bégin, Saint Mandé, 94160, France; 2Dermatol...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fougerousse AC (Author), Mery-Bossard L (Author), Parier J (Author), Taieb C (Author), Bertolotti A (Author), Maccari F (Author)
Format:	Book
Published:	Dove Medical Press, 2021-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of Systemic Medications for Treating Adult Atopic Dermatitis in France: Results of a Practice Survey
by: Fougerousse AC, et al.
Published: (2021)

Antibiotic Treatment for Hidradenitis Suppurativa in France: A Practice Survey
by: Fougerousse AC, et al.
Published: (2022)

Contraception, Sexuality and Pregnancy in Women with Psoriasis: Real-Life Experience of 235 Women
by: Maccari F, et al.
Published: (2020)

A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
by: Divyanshu Srivastava, et al.
Published: (2023)

Influence of Methotrexate on circulatory levels of T lymphocyte-related cytokines in patients with moderate to severe plaque psoriasis
by: Bei-bei SU, et al.
Published: (2020)

Weekly methotrexate versus daily isotretinoin to treat moderate-to-severe chronic plaque psoriasis: a comparative study
by: C. Abhinav, et al.
Published: (2015)

Efficacy of Leflunomide Compared to Methotrexate in the Treatment of Moderate to Severe Plaques Psoriasis: A Randomized Controlled Clinical Trial
by: Hany Aboelwafa, et al.
Published: (2024)

Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
by: Ezzedine K, et al.
Published: (2020)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
by: Gisondi P, et al.
Published: (2016)

Observational study on the therapeutic management and economic burden of adult patients with moderate to severe plaque psoriasis in France - the POP study
by: A. P. Villani, et al.
Published: (2023)

Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents
by: Audrey Melin, et al.
Published: (2021)

Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
by: Light JG, et al.
Published: (2021)

Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Ren V, et al.
Published: (2013)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Sekhon S, et al.
Published: (2017)

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
by: Jin JQ, et al.
Published: (2023)

Comparative Effectiveness and Safety of Methotrexate Versus PUVA in Severe Chronic Stable Plaque Psoriasis
by: Saikat Banerjee, et al.
Published: (2021)

Disease severity in moderate‐to‐severe plaque psoriasis: Results from the Belgian REDISCOVER study
by: Tom Hillary, et al.
Published: (2024)

The study of clinical outcome of systemic methotrexate uses in moderate to severe childhood psoriasis
by: Tarang Goyal, et al.
Published: (2017)

Impact of the COVID-19 Pandemic on Chronic Inflammatory Dermatoses: Mixed Messages Regarding the Dermatologist's Point of View and the Patient's Concerns
by: Anne-Claire Fougerousse, et al.
Published: (2020)

Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting
by: Alessio Gambardella, et al.
Published: (2023)

Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
by: A. A. Kubanov, et al.
Published: (2019)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
by: Martina Burlando, et al.
Published: (2021)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
by: Ruggiero A, et al.
Published: (2023)

Evaluation of therapeutic response of methotrexate and calcipotriol combination compared with methotrexate alone in plaque psoriasis
by: Deepthi Vasanthada, et al.
Published: (2014)

Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
by: Di Lernia V, et al.
Published: (2016)

Acute methotrexate toxicity presenting as ulcers in plaques of psoriasis vulgaris
by: Anuj Bhatnagar, et al.
Published: (2015)

Comment: Evaluation of therapeutic response of methotrexate and calcipotriol combination compared with methotrexate alone in plaque psoriasis
by: Antonio Chuh, et al.
Published: (2014)

Treatment challenges in the management of moderate-to-severe plaque psoriasis – role of secukinumab
by: Malakouti M, et al.
Published: (2016)

Apremilast and NB-UVB combination therapy in moderate-to-severe plaque type psoriasis
by: O. Yu Olisova, et al.
Published: (2020)

Clinical observation of guselkumab in the treatment of 23 cases of moderate to severe plaque psoriasis
by: Liye XIA, et al.
Published: (2024)

Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
by: Beck KM, et al.
Published: (2018)

Patient's perception and importance of clear/almost clear skin in moderate-to-severe plaque psoriasis: Results of clear about psoriasis survey in Taiwan
by: Yu-Huei Huang, et al.
Published: (2019)

Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania
by: Bucur S, et al.
Published: (2024)

Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas
by: Cacciapuoti S, et al.
Published: (2023)

Health-related quality of life among patients with moderate-to-severe plaque psoriasis in Taiwan
by: Tsen-Fang Tsai, et al.
Published: (2018)

Comparision of the efficacy and safety between Secukinumab and Adalimumab in the treatment of the moderate to severe plaque psoriasis
by: Dandan HU, et al.
Published: (2023)

Neutrophil/lymphocyte ratio as serum inflammatory biomarker in patients with moderate-to-severe plaque psoriasis
by: Maria E. Agapito-Valgas, et al.
Published: (2023)

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
by: Johansson E, et al.
Published: (2018)

Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
by: Giunta A, et al.
Published: (2017)